There have been a number of proposed advantages for follow-up care after treatment for early breast cancer, including early detection of a recurrence or new primary breast cancer, monitoring of treatment-related toxicities and provision of psychosocial support. Previous clinical practice guidelines from National Breast Cancer Centre (NBCC)** were published in 2001 which included information on follow-up care after treatment of breast cancer. National Breast and Ovarian Cancer Centre (NBOCC)* undertook a systematic review of literature published between January 2000 and January 2008 to update these guidelines. Many papers have been published on this topic during this time however a limited number of studies were identified that were considered high quality evidence, such as randomised controlled trials. ** In February 2008, National Breast Cancer Centre (NBCC), incorporating the Ovarian Cancer Program, changed its name to National Breast and Ovarian Cancer Centre (NBOCC). In July 2011, NBOCC amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.
|File size:||466.09 KB|
|Cancer Type:||Breast cancer|
|Publication Audience:||Resources for health professionals|
|Document Status:||Research and data reports
This resource is 5 years or older. It includes data or research findings at an earlier point in time and is available to the public for research and reference purposes.